Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study

Aidana Rakhmankulova, Yesbolat Sakko, Abduzhappar Gaipov, Kuralay Atageldiyeva, Talshyn Ukybassova, Assem Suleimenova, Yerbolat Iztleuov, Gulzhanat Aimagambetova · 2026

Read Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study by Aidana Rakhmankulova, Yesbolat Sakko, Abduzhappar Gaipov, Kuralay Atageldiyeva, Talshyn Ukybassova, Assem Suleimenova, Yerbolat Iztleuov, Gulzhanat Aimagambetova (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13278921.txt.

Description

Aidana Rakhmankulova and colleagues chart cervical cancer across Kazakhstan over a decade, in a 2026 nationwide study. HPV shots for girls began in 2024 in the country, so a pre-vaccine baseline matters. Registry data covered cases from 2014 to 2023.

Recorded cases climbed while incidence and death rates peaked around 2022. Five-year survival sat near sixty-five percent overall, with advanced-stage disease driving most lost years. Treatment with chemotherapy or radiation marked higher risk in adjusted models, reflecting more severe cases. Burden measures such as disability-adjusted life years also peaked in 2022. The authors offer the analysis as the benchmark for judging the years ahead.

Catalog record

CREATORAidana Rakhmankulova, Yesbolat Sakko, Abduzhappar Gaipov, Kuralay Atageldiyeva, Talshyn Ukybassova, Assem Suleimenova, Yerbolat Iztleuov, Gulzhanat Aimagambetova
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13278921

Browse the full library · About the Tower of Babel